To the full analysis
UPM-Kymmene stock: growth
UPM.HEUPM-Kymmene reported $10.7B in revenue for fiscal 2025, down 6.6% on the prior year, up 2.4% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
−0.2%
per year from 2006 to 2025, per share −0.2%
Earnings (Annual rate)
1.8%
per year from 2006 to 2025, per share 1.8%
Free cash flow (Annual rate)
2.8%
per year from 2006 to 2025, per share 2.7%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 2.4% | −0.5% | −0.2% |
| Revenue per share | 2.6% | −0.4% | −0.2% |
| Earnings | −3.0% | −6.3% | 1.8% |
| Earnings per share | −2.8% | −6.2% | 1.8% |
| Free cash flow | 49.7% | 2.6% | 2.8% |
| Free cash flow per share | 50.0% | 2.7% | 2.7% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $11.1B | $376.98M | $642.29M |
| 2007 | $11.34B | $94.19M | $214.97M |
| 2008 | $10.58B | −$198.35M | $77.57M |
| 2009 | $8.61B | $187.27M | $1.13B |
| 2010 | $9.97B | $621.64M | $821.1M |
| 2011 | $11.16B | $506.4M | $836.62M |
| 2012 | $11.57B | −$1.39B | $709.18M |
| 2013 | $11.14B | $371.21M | $441.02M |
| 2014 | $10.93B | $567.35M | $956.29M |
| 2015 | $11.23B | $1.02B | $834.4M |
| 2016 | $10.87B | $974.02M | $1.48B |
| 2017 | $11.09B | $1.08B | $1.39B |
| 2018 | $11.62B | $1.66B | $1.21B |
| 2019 | $11.34B | $1.18B | $1.6B |
| 2020 | $9.51B | $620.54M | $144.05M |
| 2021 | $10.87B | $1.43B | −$300.3M |
| 2022 | $12.99B | $1.69B | −$1.07B |
| 2023 | $11.59B | $429.94M | $1.32B |
| 2024 | $11.46B | $483.13M | $837.72M |
| 2025 | $10.7B | $531.89M | $1.08B |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 1 May 2026)
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.